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Abstract
In vitro biochemical and cell-based small molecule screens have been widely used to identify
compounds that target specific signaling pathways. But the identified compounds frequently fail at
the animal testing stage, largely due to the in vivo absorption, metabolism and toxicity of
chemicals. Zebrafish has recently emerged as a vertebrate whole organism model for small
molecule screening. The in vivo bioactivity and specificity of compounds are examined from the
very beginning of zebrafish screens. In addition, zebrafish is suitable for chemical screens at a
large scale similar to cellular assays. This protocol describes an approach for in situ hybridization
(ISH)-based chemical screening in zebrafish, which, in principle, can be used to screen any gene
product. The described protocol has been used to identify small molecules affecting specific
molecular pathways and biological processes. It can also be adapted to zebrafish screens with
different readouts.
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INTRODUCTION
The zebrafish Danio rerio has emerged as a powerful model system for small molecule
screening for novel biological and therapeutic discovery. The zebrafish system is a cost
effective and efficient vertebrate model. They propagate in large numbers with a single
mating pair producing 200-300 embryos at a time. Our lab has recently developed a
specialized breeding vessel to enhance their natural reproductive capability. This allows for
the collection of very large number of developmentally synchronized embryos in brief
windows of time and greatly accelerates the potential throughput (Adatto et al. 2011).
Zebrafish embryos can be placed into 96- to 384-well plates and readily absorb chemicals
from the water without the need for an invasive injection. Zebrafish screening is performed
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on whole embryos, providing in vivo assessment of toxicity as well as evaluation of multiple
biological pathways. Developing embryos are optically clear, allowing for in depth
visualization and monitoring of a perturbation in interested processes. More importantly, the
zebrafish is a model organism with conserved pathways, and the chemicals from zebrafish
screens typically have analogous effects on mammalian systems.
Small molecule screens in zebrafish embryos have successfully identified a number of
compounds regulating a variety of biological processes, and some of the chemicals are
starting to make it into clinic (North et al. 2007; White et al. 2011). These screens have
searched for small molecules targeting specific developmental processes or known signaling
pathways (Yu et al. 2008; Kokel et al. 2010; Molina et al. 2009). This includes finding small
molecules that suppress a mutant or diseased phenotype through a number of readouts
including behavior, morphology, and gene expression (Peterson et al. 2004; Stern et al.
2005; Yeh et al. 2009). The protocol described here utilizes in situ hybridization (ISH) as a
read-out. This assay provides visualization of localized mRNA transcripts that are expressed
in a tissue specific manner, and has been successfully employed in a number of recent
screens from our lab. Using runx1/cmyb as targets, we have previously identified
prostaglandin E2 (PGE2) pathway as a mediator of hematopoietic stem cell (HSC) formation
during developmental hematopoiesis (North et al. 2007). A stable derivative of PGE2 (dm
PGE2) significantly increased HSC repopulation in murine transplantation model. In a more
recent screen, we searched for chemical inhibitors of melanoma growth by examining
expression of crestin (the marker of melanocyte precursors) in chemical treated embryos,
and found that Dihydroorotate dehydrogenase (DHOH) inhibitors such as leflunomide
completely abrogated melanocyte precursor (neural crest cell) development and also
significantly inhibited melanoma growth (White et al. 2011). Further mechanistic studies
revealed a critical role of transcription elongation in melanocyte development and melanoma
growth. dmPGE2 and lefluonomide are currently in clinical trials for HSC transplantation
and melanoma treatment, respectively (Goessling et al. 2011; White and Zon, unpublished
data).
The protocol outlined here (Figure 1) allows one to carry out a high-throughput screen to
find compounds that target specific developmental process marked by critical signaling
molecules. Basic protocol 1 describes a breeding vessel set up for the collection of
thousands of developmentally synchronized embryos for high-throughput screening. Basic
protocol 2 illustrates the plating and chemical treatment of the embryos. Basic protocol 3
describes the ISH method for analysis of gene expression. Although this protocol illustrates
an approach for an in situ-based chemical screen, it can be easily modified to the high-
throughput screens utilizing different read-outs.
STRATEGIC PLANNING
Selection of targets and read-outs
One of the most important decisions in planning a zebrafish chemical screen is to select the
appropriate targets and read-outs. The selected target and read-out should accurately reflect
the desired process, and should also be robust, reliable and sensitive. In principle, ISH can
be used to visualize the expression of any gene product. This assay requires prior knowledge
of the biologic process and depends on the selected molecular target, which should be
critical for the developmental process. This assay also requires the development of gene
specific antisense probe and optimization of ISH condition. The support protocol in this
article describes the design and synthesis of an antisense probe. If a suppressor screen is
performed, particularly for suppressors of a homozygous recessive mutation, the high
penetrance of ISH staining phenotype in the mutant embryos is desired, which may require
the evaluation of several different molecular targets. Besides ISH for molecular targets,
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several other assays have been employed successfully in previous screens (Kaufman et al.
2009). For example, a visible morphological trait associates with the developmental process
such as the D-V axis of the developing embryos has been used a read-out (Yu et al. 2008).
This type of assay does not require much prior knowledge about the process, but the
phenotypes may not be specifically linked to the biology, and many structures like internal
organs are not easily assayable. A tissue or pathway-specific reporter transgenic zebrafish
are convenient for fluorescent imaging-based high-throughput screen (Molina et al. 2009),
but they often require the searching for a suitable promoter and generation of stable
transgenic lines.
Timing of Chemical Treatment
The appropriate timing for chemical treatment depends on the targeted gene or biological
process. Generally, chemical treatments should start before and continue until the expression
of targeted gene or the occurrence of interested process. For example, to evaluate HSC
development and specification in zebrafish, embryos are treated from 3 somite stage to 36
hours post fertilization (hpf) (North et al. 2007). In another screen searching for signals
regulating HSC migration and mobilization to the caudal hematopoietic tissue (equivalent to
mammalian fetal liver), zebrafish embryos are treated from 48 hpf to 72 hpf (Tamplin and
Zon, unpublished data). The Zebrafish Information Network (ZFIN) is a valuable online
resource that provides a comprehensive collection of gene expression data for multiple
developmental time points.
Another factor to keep in mind is toxicity; younger embryos are more vulnerable to the
harmful effects of some chemicals. In our experience, treatment before gastrulation stage
(10 hpf) and particularly before 50% epiboly stage (6 hpf), significantly increases the death
or the developmental delays of embryos as compared to the treatment after gastrulation
finishes. The early treatment can also interfere with the developmental patterning during
embryogenesis that will likely affect gene expression, and thus compound the interpretation
of results. Extended exposure to the chemicals (more than 24 hours) is also toxic to the
embryos. If the assay is read out at the late developmental stages, a wash-out step may be
added to remove the chemicals after the initial treatment. The effects from the early
chemical treatment should be monitored during the subsequent development steps.
Choosing a Chemical Library
Many chemical libraries are available from small collections of characterized compounds
with known molecular targets to larger libraries consisting of tens of thousands of
compounds of unknown function. A careful introduction and comparison of different
libraries have been discussed elsewhere (Kaufman et al. 2009). One should choose the
library based on the aimed pathways, the throughput of the assay and the cost of library.
Chemical libraries with characterized compounds are commonly used in zebrafish small
molecule screens. Once a list of validated hits is generated, the follow-up and mechanistic
studies can be quickly performed. Additional single commercial chemicals can be purchased
to further study pathways that appear significant during the screen. If a chemical library with
a large number of chemicals is selected, pooling of chemicals can be used to facilitate the
speed of the screen, which has been successfully used in the small molecule suppressor
screen of zebrafish bmyb mutants (Stern et al. 2005). But a chemical pool may result in
unexpected interactions between pooled chemicals and also increased toxicity to the
embryos. This is particularly true for libraries with bioactive compounds. In addition, one
should carefully decide the pooling strategy. For example, as in the above mentioned screen
(Stern et al. 2005), each chemical is screened twice in two different chemical pools.
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BASIC PROTOCOL 1
ZEBRAFISH EMBRYO COLLECTION
A major advantage to using the zebrafish for chemical screening is the ease and cost
effectiveness of materials. Large amounts of developmentally synchronized embryos can be
obtained all at once, allowing for reliable, high-throughput screening. Timing of embryo
collection is extremely important to ensure synchronized embryos. Our lab has recently
developed a breeding vessel to further enhance the fecundity of zebrafish (Figure 2). This
protocol describes the set-up and take-down of this system.
Materials
Solution and reagents: Zebrafish strain (a wild type strain or a specific mutant strain,
depending on the purpose of the screen)
E3 Buffer (see recipe)
Special equipment: Breeding Vessel (iSPAWN, Tecniplast)
1. On the evening prior to the morning when embryos are desired, separate the male
and female fish to be mated.
The total number of fish should not exceed 250 as it will reduce mating
performance. It may be helpful to bias the sex ratio towards males to
ensure that all females spawn immediately.
Set up zebrafish breeding vessel (Figure 2)
2 Insert the spawning platform into the chamber until the platform's bottom has
reached the cone shaped base of the chamber. Place one sex in the bottom of the
spawning platform.
3 Insert the separator and place the other sex above it. Leave the fish in the
breeding vessel over night.
Collect embryos (Figure 2)
4 On the following morning when embryos are desired, remove the separator to
allow male and females to co-exist in “deep water conditions”.
5 Raise the spawning platform to the “shallow condition” to trigger spawning
behavior. Typical spawning time is between 10-15 minutes to ensure
synchronized embryos.
6 Stop the spawning by removing the spawning platform and the fish from the
vessel.
7 Place a sieve underneath the bottom of the chamber and open the ball valve at
the bottom of the chamber, draining the water into the sieve to collect fallen
embryos from the bottom of the cylinder.
8 Rinse the embryos several times with the water and store embryos in E3 buffer
in petri dishes. Keep embryos at appropriate temperatures (25-31°C) to the
desired stages.
Do not put too many embryos on the same petri dish (maximum 800
embryos per 150-mm pertri dish and 80 embryos per 100-mm dish).
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BASIC PROTOCOL 2
ZEBRAFISH EMBRYO PREPARATION AND CHEMICAL TREATMENT
To minimize variability later on, it is important to be consistent when plating the embryos.
We recommend 10 embryos per well in 48-well or 96-well plates. If the embryos are fixed
after 24 hpf for ISH or the embryos older than 24 hpf are used for chemical treatment, 96-
well mesh filter plates can be used (See additional protocol), which allows the chemical
treatment and ISH steps performed on the same plate and greatly increases the speed of the
screen. It is important to normalize the volume in all wells so that chemical dose remains
consistent. In addition, timing is extremely important; complete each step for every plate
before moving on to the next part of the protocol. This basic protocol describes how to
chemically treat the embryos as well as prep the embryos for ISH.
Materials
Reagents: Embryos (collected from basic protocol 1 and should be plated several hours
before the desired stage, considering the timing of transferring and plating embryos)
E3 Buffer (see recipe)
Multi-well plates (48-well flat bottom plates, Falcon, cat. no. 353078 or 96-well flat bottom
plates, Costar, cat. no. 3596)
Chemical library (e.g. Chembridge DIVERSet)
DMSO
Pronase (Roche, cat. No. 11-459-643-001, dissolve in E3 buffer to 2.5mg/ml)
PBT (see recipe)
4% PFA (see recipe)
Methanol
Instrumentation: Multi-channel pipette
Multi-channel vacuum wand (optional, e.g. from V& P scientific, Inc.)
Normalization of Well Volume and Chemical Treatment
1. Clean the embryos under microscope. Remove dirt, unfertilized, and dead embryos
with a plastic pipette (see Figure 3 for examples of these embryos).
2. Transfer 10 embryos into each well of a labeled 48-well plate. Lean plates against a
support such as a pipette tip box and tap gently to collect the embryos at the bottom
of each well. Use a vacuum pipette (or a multi-channel vacuum) to remove the
liquid from each well. Use a multi-channel pipette to refill wells with 200 μl of E3.
Return embryos to appropriate temperatures until they develop to the desired stage.
The chemical treatment can be done in 48- or 96-well plates. If 96-well
plates are used, the volume of solutions in each of the following steps need
to be adjusted accordingly. If the wild type embryos are used, we
recommend 10 embryos in each well. For a suppressor screen of
homozygous mutant embryos, we recommend the use of 20 embryos from
the heterozygous adults in 48-well plates.
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3. Dilute the chemicals from the master chemical plate. Load 100 μl of E3 containing
1% DMSO to each well of 48- (or 96-) well ‘transfer’ plates. Remove 1 μl of each
chemical solution from the stock plates and place into the transfer plates. Mix the
chemicals well by rocking the plates a few times or using a liquid handling robot to
pipet the contents of each well.
We recommend 1:100 dilution of the stock chemicals and typically store
stock compounds at 10 mM, although one can choose the appropriate
dilution based on the chosen library.
4. Load the diluted chemical (100 μl) from the transfer plate into the corresponding
wells of 48-well plates that contains embryos in 200 μl of E3 using a multi-channel
pipette. Add 100 μl of the vehicle control E3 (containing only DMSO and no test
compounds) to the control wells (see Figure 4 for plate layout). Keep embryos at
appropriate temperature to proper stages.
The final dilution of the chemicals in this protocol is 1:300. Thus, if
starting with 10 mM stock compounds, the final screening concentration is
~30 μM. The final concentration of DMSO in this protocol is 0.33%. We
recommend keeping the final DMSO concentration in each well at or
below 1% in the presence of the zebrafish embryos.
Toxicity Screening
5 When embryos reach desired stages, check treated plates under a microscope for
toxicity by comparing each well to the vehicle control wells. Specifically, look
for mutant, delayed, and dead embryos. Record observations for wells with
significant numbers of abnormal or dead embryos.
Chemical removal, dechorionation, and fixation of embryos
6 Lean plates against a support and tap gently to collect embryos at the bottom of
a well. Use a vacuum pipette to remove medium in wells and refill each well
with 750μl of E3 to wash away any residual chemicals using a multi-channel
pipette.
Set plates on a black background to see the embryos clearly.
Cautions: Be sure to dispose of chemical waste in the proper container.
7 Remove E3 from wells and add back 250 μl of pronase solution. After an
approximately 10-minute incubation at room temperature (RT) or when the
chorion becomes noticeably softened, remove pronase solution and wash twice
with 750 μl of E3.
Be careful not to over-digest embryos – this limits maximum number
of plates to 7 plates processed per session per person running the assay.
8 Remove E3 and wash once with 750 μl of PBT in each well for 5 minutes.
Remove PBT and refill with 500 μl of 4% PFA. Seal each plate with parafilm
and place them at 4°C overnight.
Caution: 4%PFA is toxic, use fume hood when adding and wear proper
lab attire. Do not leave embryos in 4% PFA for more than 2-3 days.
Longer incubation in fixative will diminish the quality of ISH.
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Dehydration
9 Remove 4% PFA from wells using a vacuum pipette and dispose of waste in
proper container. Wash once with 500 μl of PBT. Replace PBT with 500 μl of
100% methanol.
For embryos older than 24 hpf, if pigmentation needs to be removed
(which may interfere with the ISH results), hydrogen peroxide
treatment can be used to remove pigments before the embryos are
dehydrated in 100% methanol (see details in Thisse & Thisse 2008).
10 Seal the plates with parafilm and place at -20 °C until ISH. The embryos may be
stored in methanol at -20°C for months.
Embryos should be left in methanol for at least 2 hours to overnight.
BASIC PROTOCOL 3
IN SITU HYBRIDIZATION STAINING OF CHEMICAL TREATED EMBRYOS
The following ISH protocol is a standard procedure as described by (Thisse & Thisse 2008).
Automation of ISH using an in situ robot such as the Biolane HTI is already available, and
has been described elsewhere (Kaufman et al. 2009). This protocol is designed for the use of
96-well mesh filter plate manually.
Materials
Solutions and reagents: Embryos (fixed and dehydrated from basic protocol 2)
96-well mesh filter plate and 96-well receiver plate (Millipore, MANM10010)
1.5 cup air tight container (Lock n’ Lock, 4.3×5.9×1.8 inches)
Methanol
PBT (see recipe)
Proteinase K solution (Roche, 03115828001, dilute in PBT to 10 μg/ml before use)
4% PFA (see recipe)
25% Glutaraldehyde (Sigma, cat. no. G4004)
Hybe+ (see recipe)
DIG-labeled RNA probe (prepared as support protocol)
Hybe – (see recipe)
2XSSC (see recipe)
0.2XSSC (see recipe)
Blocking Solution (see recipe)
Anti-DIG-AP antibody (Roche, cat. no. 11 093 274 910)
Prestain Solution (see recipe)
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Staining buffer (see recipe)
Stop solution (see recipe)
Spot plates in white porcelain, 12 cavities (Fisher, cat. no. S337241)
96 well round bottom plate (BD, cat. no. 353227)
Special equipment: Belly dance rotator (STOVALL life science Inc.)
70°C incubator (Thermo Electron)
Microscope (Zeiss Stereo Discovery.V8)
ISH of embryos
1. Place a 96-well mesh filter plate into a sealable Lock n’ Lock container, and fill the
plate with methanol. Transfer the embryos from 48-well plates by plastic transfer
pipette into the corresponding wells of the mesh filter plate (see Figure 4 for plate
layout).
-Be very careful when transferring the embryos to retain the well order.
-We recommend washing and incubating embryos in 30-50 ml of solution
per 96- well per wash/incubation step within this protocol.
-Seal the Lock-n-Lock container for all incubations, particularly for the
steps performed at 70°C
2. Wash the embryos with a successive mixture of methanol : PBT (2:1 for 5 minutes,
then 1:2 for 5 minutes) at RT. Perform four washes with 100% PBT, 5 minutes
each. Place plates on a swirling rotator for this and the following wash steps. If
embryos are older than 10-somite stage, proteinase K treatment (10 μg/ml) at RT is
necessary after PBT wash steps.
Suggested proteinase K treatment time:
10 som-20 som: 1 minute
20 som-26 som: 2minutes
26 som-24 hpf: 6-10 minutes
36hpf- 48 hpf: 12 minutes
Note: Excessive proteinase K treatment will make embryos disintegrate
during the ISH procedure.
3. If proteinase K treatment is applied, quickly wash out the proteinase K solution
once, using PBT. Whether or not using proteinase K, next fix the embryos with 4%
PAF + 0.2% glutaraldehyde at RT for 20 minutes.
The addition of 0.2% glutaraldehyde helps to maintain the integrity of
embryos and to reduce the background staining. Prewarm the hybe+ and
RNA probe solution in the 70°C incubator for the next step.
4. Remove the fixing solution and wash four times with PBT at RT for 5 minute each
time. Replace PBT with Hybe+, and leave the plate in the 70°C incubator for 1-3
hours. Change the Hybe+ buffer with the DIG-labeled RNA probe (~1ng probe /μl
Hybe+ buffer). Leave the incubation at 70°C overnight.
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5. Remove the RNA probe and collect the used probe in a separate container.
Continue the next series of washes in the 70°C incubator with gentle agitation. Start
with a 5 minute wash of Hybe- buffer, then three 10 minute washes of a series of
Hybe- : 2XSSC mixtures, with increasing ratios (3:1, 1:1, 1:3). Do a final wash of
100% 2XSSC for 10 minutes, then two 30 minute washes of 0.2XSSC.
The RNA probe solution can be reused for at least 3 times and should be
stored at -20°C. To remove the residual liquids retained in the mesh-
bottom plate, use a kimwipe paper to blot the bottom of the mesh plates
before putting in new solution.
All solutions should be warmed to 70°C before use.
6. Perform the following washes at RT on a swirling rotator. Three 10-minute washes
with 0.2XSSC : PBT at gradually increasing ratios (3:1, 1:1, 1:3). One 10-minute
wash with 100% PBT. Finally, block the embryos in blocking solution for 3-4
hours at RT.
7. Replace blocking solution with anti-DIG antibody solution diluted at 1:5000 in
blocking solution. Incubate overnight at 4°C on a swirling rotator.
8. The final washes are to be done at RT on a swirling rotator. Wash with PBT five
times for 15 minutes each. Remove all PBT solution by blotting the bottom of the
plate with a Kimwipe and add prestain solution. Prestain the embryos for at least 10
minutes, then replace with staining buffer (prestaining + BCIP and NBT; see
recipe). Cover the plates with aluminum foil and check on the staining every hour.
The prestaining buffer needs to be carefully adjusted to pH 9.5 to avoid
non-specific purple precipitation. The time required for proper staining
color reaction depends on the gene examined and could range from 15
minutes to 1 or 2 days.
9. When the staining is done, deposit staining solution in waste container and rinse the
plates once with PBT for 5 minutes. Replace with stop solution and store in 4°C in
an airtight lock n’ lock container in the dark.
Scoring of embryos
10 When scoring the in situ results, transfer the embryos from the mesh plates to
observation spot plate. Use toplighting and a white background to view and
compare the chemical treated embryos to the vehicle treated embryos from the
same plate (see Figure 5 for an example of in situ staining after chemical
treatment). Record changes in staining results such as intensity and size. Take
pictures for the potential hits. After the scoring, transfer the embryos to a 96-
well round bottomed plate. They can be sealed and kept at 4°C.
It is helpful to use a quantitative scoring system to specify the changes.
Being familiar with the control stainings including the vehicle controls,
positive and negative controls will help one to discern differences in
the chemically treated embryos. The stained embryos can be kept in
stop solution at 4°C in the dark for several months.
SUPPORT PROTOCOL
SYNTHESIS OF AN ANTISENSE RNA PROBE
To generate the antisense probe for ISH, the 3’ prime end of a gene including the 3’ UTR is
often used as a template (generally 200 bp to 1kb in length). It is better to use gene specific
sequence to make antisense probe, although the full length cDNA can also be used to
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generate efficient probes. The probes are reuseable, and often get better with more use. This
protocol describes the method of making probes from a cDNA template from plasmids.
Alternatively, PCR amplification using primers containing a T3 or T7 polymerase promoter
can be used to prepare DNA template (Thisse & Thisse 2008).
Materials
Solutions and reagents: The vector with the cDNA template for the probe (It should
contain a T3, T7 or SP6 RNA polymerase promoter around the cDNA insert)
Restriction enzyme digestion reagents (New England Biolabs)
DEPC H2O (see recipe)
Phenol:Chloroform:isoamyl alcohol (25:24:1, Sigma, cat. no. P2069)
Chloroform:isoamyl alcohol (24:1, Sigma, cat. no. C0549)
Agarose
1X TBE (see recipe)
3 M Sodium Acetate pH 5.5 (Ambion, cat. no. 9740)
Ethanol
70% ethanol in DEPC H2O (vol/vol)
DIG RNA labeling mixture
10X transcription buffer (Roche, cat. no. 14735400)
NTP DIG labeling mix labeling mixture (Roche, cat. no. 11277073910)
Appropriate RNA polymerase (T3, Promega, cat. no. P207C; T7, Promega, cat. no. P207B;
SP6 Promega, cat. no. P207A)
RNAse inhibitor (RNasein, Promega, cat. no. N2511, 40 u/μl)
RNase free DNase I (Roche, cat. no. 04716728001, 10 u/μl)
1M Lithium Chloride
To avoid contamination, be sure to use clean tips and make any transfers into clean tubes.
Unless they are incubating, keep tubes on ice as much as possible.
Special equipment: NanoDrop Spectrophotometer (Thermo Scientific, NanoDrop 2000)
Preparation of linearized cDNA template
1. The vector with the cDNA should contain a T3, T7 or SP6 RNA polymerase
promoter around the cDNA insert. Pick a restriction enzyme (RE) that has a unique
site located at 5’ of cDNA to make the antisense probe. In a microfuge tube, mix
5-10 μg DNA plasmid with 3-4 μl RE in a 100 μl reaction volume, and digest at an
appropriate temperature for 2-6 hours. Use 2μl of the reaction to run 1.2% agarose
gel in TBE to check the digestion.
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Complete digestion of the plasmid should yield only one band on the gel.
2. Purification of DNA template by phenol/chloroform extraction. Add 100 μl of
phenol: chloroform :isoamyl alcohol (25:24:1) to the digestion, tap tube lightly to
mix, and centrifuge at top speed for 3 minutes at RT. Transfer upper phase to a new
microfuge tube and add 100 μl of chloroform :isoamyl alcohol (24:1). Tap and
centrifuge again for 3 minutes.
Take care not to transfer any of the bottom phase to the new tube. Phenol
and chloroform are toxic, so collect them and dispose used tubes in an
appropriate waste container.
3. Transfer upper phase to a new tube, then add 10 μl of 3M sodium acetate (pH 5.5)
and 200 μl of 100% Ethanol. Vortex 10 seconds and let precipitate in -20°C for at
least 2 hours to overnight.
4. Centrifuge at 12000g for 15 minutes at room temperature. Carefully decant the
supernatant.
5. Wash the pellet in 70% ethanol-DEPC H2O. Centrifuge for another15 min 12000g
at RT. Remove the supernatant. Air-dry the pellet for about 10 minutes (Do not
over dry the pellets). Add 10.5 μl DEPC H2O to dissolve the pellet. Take 1 ul to
measure the concentration (μg/mL) by NanoDrop spectrophotometer, using DEPC
H2O as blank.
Synthesize and purification of DIG-labeled antisense RNA probe
6 Add the following items to a microfuge tube:
1 μg DNA template + DEPC H2O to 13 uL
2 μl 10X transcription buffer
2 μl NTP DIG labeling mixture
2 μl RNA polymerase (T3, T7 or SP6)
1 μl RNase inhibitor
Incubate for 2 hours at 37°C. Add 1 μl DNase I and incubate at 37°C for 20
minutes to stop the reaction. Take 1 μl to run on a 1.2% agarose gel to check
RNA probe.
A good probe should appear as 1 or several distinct bands on the gel. A
smear usually indicates degradation.
7 Add 6 μl of DEPC H2O and 75 μl of 100 % ethanol to the probe tube, mix well.
Add 10 μl of 1M Lithium Chloride and precipitate RNA probe overnight at
-20°C.
8 Centrifuge at 4°C, 12000g for 30 minutes. Wash resulting pellet with 70%
ethanol-DEPC H2O. Centrifuge at room temperature at 8000g for 5 minutes. Air
dry for 5-10 minutes. Add 100 μl DEPC H2O to dissolve the pellet and 40 units
of RNasin to prevent RNase activity. Measure the concentration of probe using
spectroscopy. Store the probe at -20°C.
ADDITIONAL PROTOCOL
CHEMICAL TREATMENT OF EMBRYOS IN 96-WELL MESH FILTER PLATES
If zebrafish embryos older than 24 hpf are fixed for ISH after chemical treatments, or the
embryos older than 24 hpf are used for chemical treatment, the chemical treatment can be
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done in 96-well mesh filter plates. The subsequent dechorination and in situ hybridization
can be done in the same plates. This will save lots of time during the washing steps after
chemical treatment and the embryo transferring procedure.
Additional materials—96-well mesh filter plate (Pion, cat. no. PN 120655)
96-well receive plate (Millipore, cat. no. MATRNPS50)
Multiscreen single well culture tray (Millipore, cat. no. MAMCS0110)
1. Place the mesh filter plate in single well receiving plate with adequate amount of
E3 to cover the wells of the mesh filter plate. Place ~10 embryos in each well and
keep the embryos at appropriate temperature to the expected stage.
If embryos older than 24 hpf are used for chemical treatment, dechorionate
the embryos first and carefully transfer them to 96-well mesh filter plate.
Let the embryos grow in mesh filter plate to desired stage and then follow
step 2, step 3 and step 5. Note: The 96-well mesh plate and the receiver
plate from basic protocol 3 can be used instead after the dechorionation for
embryos older than 24 hpf.
2. Dilute the chemicals from the master plate into a 96-well transfer plate. Take 1μl
chemical from the stock plate and transfer it to the 96-well plate containing 300 μl
of E3 (1:300 dilution of chemicals) plus 1 ul DMSO (0.33%) in each well including
controls as shown in Figure 4.
3. Take the mesh filter plate from the single well receiving plate, wipe out extra liquid
with Kimwipes. Transfer the mesh plate into the 96-well receive plate with the
diluted chemicals in each well, being sure to align the wells and avoid spilling.
Cover the plate and return the embryos to the incubator.
4. When the embryos reach the expected stage, carefully take the mesh plate out of
the chemical plate, and wash out the chemicals in an appropriate container like a
150-mm petri dish. Leave embryos in pronase solution for 10 minutes in the
container, and gently shake a few times during the incubation. Take the plates out
of pronase solution, and wash several times with E3. Wash once with PBT.
Carefully move the plate up and down out of solution to wash out the
chonrion debris. The mesh surface may be too rough for the embryos to be
pressed or scratched against it without causing damage. It should be noted
that only embryos old enough (>24hpf) would remain intact in this mesh
bottom plate during this procedure.
5. Transfer the mesh filter plate into an airtight container. Fix the embryos in 4% PFA
at 4°C overnight. Follow the rest of the steps from basic protocol 2 and 3 to finish
the ISH.
REAGENTS AND SOLUTIONS
E3 buffer (embryo water)—Prepare a 50X stock and store up to 1 year at RT
1L deionized H2O
14.61g NaCl
0.63g KCl
2.43g CaCl2.2H20
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1.99g MgSO4
Dilute to 1X in deionized H2O before use.
Phosphate buffer saline with Tween 20 (PBT)—900ml double distilled water
100ml 10X Phosphate Buffered Saline (PBS) (Fisher Scientific, cat. no. BP3994)
1ml Tween-20 (American Bioanalytical, cat. no. AB02038-01000, final concentration 0.1%)
Store up to 1 year at RT
4% PFA (wt/vol)—Dissolve Paraformaldehyde (PFA, Electron Microscopy Sciences, cat.
no. 19210) in 1XPBS in a chemical fume hood. Heat until the powder has dissolved
completely (Never boil the solution!). Cool to RT before use. If stored at RT, the solution
can be used for a couple of days. Alternatively, it can be frozen at -20°C for months and
thaw just before use.
Hybe+—500 ml 100% formamide (Invitrogen, cat. no. 15515-026)
250 ml 20X SSC
1ml Tween-20
50 μg/ml heparin (Sigma, H3393)
500 μg/ml total yeast RNA (Sigma, R6625)
Add DEPC H2O to final volume of 1L
Store up to 1 year at -20°C
Hybe-—Leave out heparin and total yeast RNA in Hybe+
20X SSC—175.3g NaCl
88.2g Citric acid trisodium salt
Dissolve in 1 liter of double distilled water
Store up to 1 year at RT
2X SSC—Dilute 20X SSC in double distilled water to 2X
DEPC H2O—Add 1ml of 0.1% Diethylpyrocarbonate (DEPC, Sigma, cat. no. D5758) to
1000 ml distilled water. Mix well and let set at room temperature for 1 hour to overnight.
Autoclave at 121°C for 20 minutes. Cool to room temperature prior to use. Store at RT for
several months
Blocking solution—50 ml PBT
100 mg Bovine serum albumin (BSA, sigma, cat. no. A2135-10G)
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1 ml heat inactivated lamb serum (GibcoBRL, cat. no. 16070 096). To heat inactivate, warm
at 55°C for 30 minutes, aliquot into small tubes and store at -20°C up to 1 year. Prepare
fresh before use
Prestain solution—10 ml Tris pH 9.5 (Dissolve 121.1 g of Trizma base in 900 ml of
water, adjust pH to 9.5 by adding HCl, and then adjust the volume to 1 L by adding distilled
water)
5ml 1M MgCl2
2ml 5M NaCl
50 μl Tween-20
Add distilled H2O to 50 ml, prepare fresh before use.
Staining buffer—4.5 ul/ml NBT (nitroblue tetrazolium, Promega, cat. no. S3771)
3.5 ul/ml BCIP (5-bromo-4-chloro-3-indolyl phosphate, Promega, cat. no. S3771)
In prestaining buffer, prepare fresh and cover with aluminum foil.
Stop solution—1X PBS pH5.5 (Adjust pH with HCl)
1mM EDTA
0.1% Tween-20
Store up to 1 year at RT
1XTBE buffer—12.1 g Trizma base
0.75 g EDTA
7.6 g boric acid
Dissolve in 1 L of water.
Store up to 1 year at RT
COMMENTARY
Background information
Previous large-scale genetic screens in zebrafish have generated thousands of mutations and
identified numerous genes that govern essential developmental processes including
organogenesis, physiology and behavior (Patton & Zon 2001; Zon & Peterson 2005). In
recent years, zebrafish have been increasingly used for screening small molecules for their
effects on development as well as on disease models. These screens have identified a variety
of signaling pathways affecting different biological phenotypes. Compared to traditional
genetic screening, small molecule screening offers several advantages. First, small
molecules provide a more precise temporal control of the target genes and the effect on
target genes are often reversible by allowing addition and removal of a compound at
selected time periods. This is particularly useful to study the function of genes that play
dynamic roles during different developmental stages. In addition, as a conditional approach,
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chemical screen have the potential to identify signals that may not be found through
traditional genetic approaches. Second, a small molecule can modulate multiple targets from
a same protein family, and thus avoiding the difficulty to make combined genetic knockout
animals to study the genes with multiple copies or isoforms in genome. Third, the identified
chemicals can not only be used as new molecular tools to modify the affected biological
process, but also have the potential to be transferred to therapeutic applications.
In vitro protein and cell-based assays are frequently used to screen for small molecules
targeting specific signaling pathways. As a whole organism screening system, zebrafish
screening has its own advantages, and provides the potential to identify compounds that may
not be found in cell-based screens. It allows one to visualize the molecular pathway in native
cell types and in the physiological context, and has the ability to detect the in vivo
absorption, distribution and metabolism of the chemicals that cannot be evaluated in cell-
based assays. For example, using phosphor-histone H3 as a mitotic marker, our lab has
screened a 16320-compound library for cell cycle inhibitors in zebrafish embryos and
identified 14 chemicals that had not been previously linked to cell cycle activity despite
numerous mitotic screens of the same library with mammalian cell lines (Murphey et al.
2006), demonstrating the effectiveness of using zebrafish to identify chemicals with novel
activity. In support of the utility of zebrafish screens, about half of the chemicals have
confirmed activities in mammalian cells (Murphey et al. 2006). Furthermore, the off-target
side effects and drug toxicity, which may be missed in cellular assays and are frequently
challenges encountered at the stages of animal testing, are evaluated from the very
beginning of zebrafish screens.
Critical Parameters
Dilution of the stock chemicals—Before beginning the experiments, several key
conditions must be carefully evaluated. The concentration of chemicals is one of them. In
our experience, different dilutions of the chemicals from a stock library (such as 1:300 vs.
1:1200 dilution) could result in different hits. As a good starting point, a final compound
concentration between 10 μM-20 μM can be used in the initial screen. At higher doses, the
compounds may have significant off-target effects. A pilot screen with about 400 chemicals
is highly recommended to estimate the death rate and “hit” rate and to find a proper dilution
range of the chemicals. Overall, it is acceptable that less than 10% compounds cause death
or severe developmental delay of the embryos after the treatment. The toxic compounds can
then be retested at a lower concentration.
Experimental Controls—There are many opportunities for variability during the
chemical screening process, making it important to have reliable controls. A positive control
will help you to set up an appropriate experimental design. Including a positive control for
chemical treatment will confirm the success of each treatment round, and allow you to
properly assess potential hits. Both positive and negative (vehicle only) controls are helpful
in dealing with staining variability. It is not uncommon to see a great deal of variation in
staining between different locations on the plate as well as within individual wells. We
recommend using negative and positive controls in multiple wells on each plate to fully
assess staining variability. If a positive control is not available, a mutant or a morphant can
be used as a substitute.
Stages of embryos—The stages of the embryos greatly affect the expression of many
developmental genes. If more than 3000 embryos are employed in a given round of
screening, the stages of the embryos could be variable, which may result in variations in the
expression of targeted genes and also affect the chemicals’ effect as a given chemical may
only function during a specific developmental time. The massive mating system using the
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breeding vessel from basic protocol 1 will significantly help reduce heterogeneity of
embryonic stages. Alternatively, multiple mating pairs could be set up separately and
embryos collected over a short period of time (i.e. 10 minutes). One should carefully stage
the embryos from each clutch before pooling them together. After the chemical treatment,
the development of the embryos should be examined prior to chorion removal and fixation.
Familiarity with the staging of the embryos and the staining of targeted genes at various
stages will facilitate to determine if the alterations of staining is from the chemical treatment
or simply due to the stage differences. To help staging, a morphology marker or a second in
situ marker that indicates the developmental stages can be used.
Troubleshooting
High background and variations of ISH staining—If embryos appear deep blue/
purple after the staining, one can shorten the incubation time in the staining buffer and
carefully wrap the containers with alumni foil to avoid light exposure. The condition for
each new antisense probe must be individually optimized before the screen. For example,
the concentration of the probe and the DNA sequence used to generate the antisense probe
should be carefully tested first in microfuge tubes, and then further optimized in multi-well
mesh plates. The new probe usually gives high background in the first time use. Preclearing
the probe with wild type embryos for several times will help to reduce the background.
The in situ staining results may be quite variable. It is strongly recommended to test control
or untreated embryos on a multi-well plate first to get familiar with the basal staining and
the inherent variability of the staining. Multiple controls including the negative control
(vehicle alone) and the positive control that produces the desired readout (if available)
should be included on each plate to monitor the quality of ISH. It could also happen that the
staining on the outside wells of the multi-well plate is lighter than the embryos in the center
of the plate. If this happens, the outside wells can be used for control/untreated embryos or
simply left empty. A second ISH marker that does not crosstalk with the targeted pathway
can be included as an internal control for the staining intensity.
Too few or too many “hits” from the screen—It is possible that the majority of
chemicals will give mild alterations in probe staining, particularly if the chemicals that
increase the gene expression are pursued. Not every embryo will respond to the chemical
treatment. In a given well of 8-10 embryos, if 30-50% of embryos demonstrate alterations in
staining, the chemical may be considered as a hit. In the follow-up testing, the chemical can
be tested at a higher dose or a related more “active” molecule can be tested.
If too many hits are found from the screen, it may come from the technical and biological
variation associated within ISH of the target genes. The chance of “false positive” correlates
with the strength of the phenotype. A quantitative scoring system will help to reveal the
spectrum of the phenotypes and prioritize the chemicals for follow-up.
Anticipated Results
This protocol will allow one to identify the small molecules that modulate the targeted
pathway or biological process. Depending on the specific phenotype, a 0.5-5% hit rate is
possible. After the potential hits are isolated, it is necessary to repeat and validate the effect
of chemicals. The promising compounds should also be tested in a wide dose range, for
example, at 1, 5, 20, 50,100 μM. An effective chemical should mediate the targets in a dose-
dependent manner.
For example, in the aforementioned screen for small molecules inhibiting neural crest
progenitors (the crestin+ lineage), White et al found that 3% of the screened chemicals
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significantly reduced crestin staining (White et al. 2011). Among those chemicals, a
molecule of unknown function, NSC210627, almost completely abolished the expression of
crestin at 40 μM (Figure 5b). Further analysis using chemoinfomatic algorithm
DiscoveryGate revealed the structural similarity between NSC210267 and brequinar, a
DHODH inhibitor. NSC210627 inhibited DHODH activity in vitro. Another DHODH
inhibitor, leflunomide, phenocopied NSC210627 (Figure 5c). Due to its availability,
leflunomide was then used in the subsequent studies and the following clinical studies.
Time consideration
A summary of approximate time for collecting embryos, chemical treatment and ISH is
shown in Figure 1. For experienced eyes, it takes about 2 hours to score the staining results
of embryos on one 96-well plate. After assay development and optimization, one person can
screen 500-1000 chemicals in two weeks. But, validating the identified hits will take much
more time.
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Figure 1. Flow chart showing the procedures of a zebrafish chemical screen with in situ
hybridization (ISH) as a read-out
O/N, overnight; AP, alkaline phosphatase.
Jing et al. Page 19
Curr Protoc Chem Biol. Author manuscript; available in PMC 2012 December 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 2. Schematic describing the operation of the breeding vessel (iSpawn)
(a) Insert the mesh spawning platform into the vessel and fill up the vessel with water. Place
male fish above the spawning platform. (b) Place mesh separator into the vessel so male fish
are confined in the bottom half of the iSpawn. (c) Add in female fish above the separator.
Allow fish to prime overnight. (d) On the next morning, remove the separator so that male
and female fish mix in the deep water. (e) Raise the spawning platform so that fish are in
shallow water. Allow fish to spawn for desired time (around 10 minutes). (f) Remove the
spawning platform and fish to stop spawning. Place a strainer at the bottom of the vessel.
Open the valve and drain the water into the strainer. Collect the fallen embryos.
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Figure 3.
Representative images of normal embryos (a), unfertilized embryos (b) and dead embryos
(c) at 6 hours post fertilization.
Jing et al. Page 21
Curr Protoc Chem Biol. Author manuscript; available in PMC 2012 December 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 4. Schema showing 48-well and 96-well plate layouts for chemical treatment and ISH
(a) For 48-well plate, columns 1 and 6 can be treated with vehicle (DMSO),the negative
control, and positive controls. The rest of the wells can be filled with test chemicals. (b)
When two 48-well plates are combined to one 96-well mesh filter plate for ISH, one plate of
samples (rotated 90 degrees) can be plated on the left side of the 96-well plate, and the other
plate can be plated on the right side of the 96-well plate. If a 96-well plate is used in the
chemical treatment, rows A and H can be used for negative and positive controls.
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Figure 5. ISH of neural crest progenitor marker (crestin) in 24 hpf embryos following chemical
treatment
DMSO (a) is used as a control for crestin expression. Treatment with NSC210627 (b)
completely abrogated crestin levels. Based on structural similarities the authors tested
Leflunomide (c) that was not found in the original chemical library, but displays robust
reduction in crestin expression. (Adapted from White et al. 2011)
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